Opposite effects of gamma(1)- and gamma(2)-melanocyte stimulating hormone on regulation of the dopaminergic mesolimbic system in rats

Neurosci Lett. 2004 May 6;361(1-3):68-71. doi: 10.1016/j.neulet.2003.12.006.

Abstract

By use of the brain microdialysis technique we show that administration of gamma(1)-melanocyte stimulating hormone (gamma(1)-MSH) into the ventral tegmental area of anaesthetized rats causes an increase in the release of extracellular dopamine and its metabolite 3,4-dihydroxyphenylacetic acid in the nucleus accumbens, while gamma(2)-MSH causes the opposite effect. Moreover, gamma(2)-MSH pre-treatment considerably reduced the gamma(1)-MSH-induced effects. Our findings suggest an opposing action of two gamma-MSH-activated pathways on the mesolimbic dopaminergic system, which could be important in the maintenance of a balanced psychoactivation state.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3,4-Dihydroxyphenylacetic Acid / metabolism
  • Animals
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology
  • Dopamine / metabolism*
  • Limbic System / drug effects*
  • Limbic System / metabolism
  • Male
  • Neural Pathways / drug effects*
  • Neural Pathways / metabolism
  • Neurons / drug effects
  • Neurons / metabolism
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Up-Regulation / drug effects
  • Up-Regulation / physiology
  • Ventral Tegmental Area / drug effects*
  • Ventral Tegmental Area / metabolism
  • gamma-MSH / metabolism
  • gamma-MSH / pharmacology*

Substances

  • gamma-MSH
  • 3,4-Dihydroxyphenylacetic Acid
  • Dopamine